C-reactive protein as an early marker of immune-related adverse events.
Amir-Reza AbolhassaniGerold SchulerMichael Constantin KirchbergerLucie HeinzerlingPublished in: Journal of cancer research and clinical oncology (2019)
CRP elevation can predict the onset of irAEs in patients treated with ICIs in the absence of infectious disease.
Keyphrases